Cargando…

Interferon-alpha-2b/oseltamivir/umifenovir: Worsening of liver function impairment following exposure to off label drugs in pregnancy: case report

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7644993/ http://dx.doi.org/10.1007/s40278-020-85359-8

Ejemplares similares

Moxifloxacin/umifenovir: Pancytopenia and off label use: case report
Publicado: (2021)

Moxifloxacin/umifenovir: Lack of efficacy following off-label use: case report
Publicado: (2021)

Immune globulin/umifenovir: Off-label use and lack of efficacy: case report
Publicado: (2021)

Methylprednisolone/umifenovir interaction: Sinus bradycardia and off label use: case report
Publicado: (2022)

Lopinavir/ritonavir/umifenovir: Nausea, vomiting and diarrhoea following off-label treatment: case report
Publicado: (2021)

Meropenem/moxifloxacin/umifenovir: QT interval prolongation and off label use: 2 case reports
Publicado: (2021)

Chloroquine/lopinavir/ritonavir/umifenovir: QTc interval prolongation, drug interaction and off-label use: 2 case reports
Publicado: (2020)

Antioxidant Potential of Antiviral Drug Umifenovir
por: Proskurnina, Elena V., et al.
Publicado: (2020)

Hydroxychloroquine/oseltamivir: Various toxicity following off label therapy: case report
Publicado: (2020)

Oseltamivir: Immune thrombocytopenic purpura following off-label use: case report
Publicado: (2020)

Cefuroxime/oseltamivir: Lack of efficacy following off label use: case report
Publicado: (2021)

Azithromycin/hydroxychloroquine/oseltamivir: Urticarial reactions following off label use: case report
Publicado: (2020)

Reinforcing the supply chain of umifenovir and other antiviral drugs with retrosynthetic software
por: Lin, Yingfu, et al.
Publicado: (2021)

Lopinavir/ritonavir: Worsening of liver injury following off-label use: 7 case reports
Publicado: (2020)

Hydroxychloroquine/oseltamivir: Exacerbation of psoriasis during off-label use: case report
Publicado: (2020)

Favipiravir/hydroxychloroquine/oseltamivir: Tonic clonic seizures following off label use: case report
Publicado: (2020)

Antibacterials/hydrocortisone/oseltamivir: Primary gastric mucormycosis following off label use: case report
Publicado: (2021)

Multiple drugs: Lack of efficacy and worsening of fusarium keratitis following off-label use: case report
Publicado: (2022)

Oseltamivir: Osborn wave associated with intramyocardial electrolyte imbalance following off-label use: case report
Publicado: (2022)

Methylprednisolone: Worsening hyperglycaemia and off-label use: case report
Publicado: (2021)

Author Correction: Reinforcing the supply chain of umifenovir and other antiviral drugs with retrosynthetic software
por: Lin, Yingfu, et al.
Publicado: (2022)

Oseltamivir in pregnancy and birth outcomes
por: Ehrenstein, Vera, et al.
Publicado: (2018)

Multiple drugs: Alloantibodies development, pregnancy exposure and off-label use: case report
Publicado: (2022)

Potential of antiviral drug oseltamivir for the treatment of liver cancer
por: Huang, Pei-Ju, et al.
Publicado: (2021)

Norepinephrine/oseltamivir: Lack of efficacy and invasive pulmonary aspergillosis secondary to off-label use: case report
Publicado: (2020)

Effect of Arbidol (Umifenovir) on COVID-19: a randomized controlled trial
por: Nojomi, Marzieh, et al.
Publicado: (2020)

Arbidol (Umifenovir): A Broad-Spectrum Antiviral Drug That Inhibits Medically Important Arthropod-Borne Flaviviruses
por: Haviernik, Jan, et al.
Publicado: (2018)

Antiviral drug Umifenovir (Arbidol) in municipal wastewater during the COVID-19 pandemic: Estimated levels and transformation
por: Ul'yanovskii, Nikolay V., et al.
Publicado: (2022)

Multiple drugs: Lack of efficacy, off label use and exposure during pregnancy: case report
Publicado: (2022)

Lopinavir/ritonavir/oseltamivir/warfarin interaction: Increase in the INR and alanine aminotransferase following off label use: 10 case reports
Publicado: (2020)

Multiple drugs: QTc prolongation, hyperglycaemia, off label use and drug exposure during pregnancy: case report
Publicado: (2021)

Interferon Lambda Delays the Emergence of Influenza Virus Resistance to Oseltamivir
por: Medaglia, Chiara, et al.
Publicado: (2021)

Dexamethasone/tocilizumab: Worsening of hepatitis E virus infection following off label use: case report
Publicado: (2022)

Revisiting the Solubility–Permeability Relationship with Hydrophobic Drug Umifenovir in Pluronic Solutions: Impact of pH and Co-Solvent
por: Volkova, Tatyana, et al.
Publicado: (2023)

Multiple drugs: Lack of efficacy, off-label use and exposure during pregnancy: 3 case reports
Publicado: (2022)

Tocilizumab: Infection and worsening of pre-existing COVID-19 symptoms following off-label treatment: case report
Publicado: (2021)

Multiple drugs: Euglycaemic diabetic ketoacidosis, lack of efficacy and off-label use following exposure during pregnancy: case report
Publicado: (2022)

Umifenovir in hospitalized moderate to severe COVID-19 patients: A randomized clinical trial
por: Alavi Darazam, Ilad, et al.
Publicado: (2021)

Dexamethasone: Worsening of Kaposi sarcoma secondary to human herpes virus-8 following off-label use: case report
Publicado: (2021)

Umifenovir treatment is not associated with improved outcomes in patients with coronavirus disease 2019: a retrospective study
por: Lian, N., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mnn0oeh98j935iuc0jjavsvvp0